A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01)

BACKGROUND: Although surgery is the definitive curative treatment for biliary tract cancer (BTC), outcomes after surgery alone have not been satisfactory. Adjuvant therapy with S-1 may improve survival in patients with BTC. This study examined the safety and efficacy of 1 year adjuvant S-1 therapy f...

Descripción completa

Detalles Bibliográficos
Autores principales: Itano, Osamu, Takemura, Yusuke, Kishida, Norihiro, Tamagawa, Eiji, Shinozaki, Hiroharu, Ikeda, Ken, Urakami, Hidejiro, Ei, Shigenori, Hayatsu, Shigeo, Suzuki, Keiichi, Sakuragawa, Tadayuki, Ishii, Masatsugu, Shito, Masaya, Aiura, Koichi, Fujisaki, Hiroto, Takano, Kiminori, Matsui, Junichi, Minagawa, Takuya, Shinoda, Masahiro, Kitago, Minoru, Abe, Yuta, Yagi, Hiroshi, Oshima, Go, Hori, Shutaro, Kitagawa, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379785/
https://www.ncbi.nlm.nih.gov/pubmed/32703191
http://dx.doi.org/10.1186/s12885-020-07185-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379785/
https://www.ncbi.nlm.nih.gov/pubmed/32703191
http://dx.doi.org/10.1186/s12885-020-07185-6

Ejemplares similares